Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Barrett Esophagus × Biopsy × Clear all

Phase

Phase NA 3 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 3 Burkitt Lymphoma 3 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Leukemia, Myelomonocytic, Chronic 2 Ganglioneuroblastoma 2 Breast Neoplasms 2 Teratoma 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

X-Rays 1 Omeprazole 1 Melatonin 1 Esomeprazole 1 Endoscopy, Digestive System 1 Endoscopy 1 Blood Specimen Collection 1 Biopsy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡